Duality Advisers, LP Allakos Inc. Transaction History

Duality Advisers, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 09, 2022	SELL	$5.08 - $9.81 $1.43 Million - $2.76 Million	-281,193 Closed	0 $0
Q4 2021 Feb 02, 2022	BUY	$8.55 - $111.89 $2.4 Million - $31.5 Million	281,193 New	281,193 $2.75 Million
Q3 2021 Nov 08, 2021	SELL	$76.53 - $110.43 $1.23 Million - $1.77 Million	-16,061 Closed	0 $0
Q2 2021 Aug 09, 2021	BUY	$85.37 - $114.1 $1.37 Million - $1.83 Million	16,061 New	16,061 $1.37 Million

64.7M

47.1K

Ticker ALLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,726,096
Market Cap $89.8M
Description
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...

Get notified when there are updates to the investment portfolio of Duality Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Duality Advisers, LP with notifications on news.